Mechoulam Raphael, Peters Maximilian, Murillo-Rodriguez Eric, Hanus Lumír O
Department of Medicinal Chemistry and Natural Products, Hebrew University Medical Faculty, Jerusalem 91120, Israel.
Chem Biodivers. 2007 Aug;4(8):1678-92. doi: 10.1002/cbdv.200790147.
The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non-psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly attractive therapeutic entity.
本综述的目的是介绍一些关于大麻二酚(CBD;2)的近期出版物,大麻二酚是大麻的一种主要非精神活性成分,并给出一个总体概述。特别强调生化和药理学进展,以及最近提出的新机制,以阐明一些可能通过这些机制得到合理解释的药理作用。观察到的CBD大量积极药理作用使这种化合物成为一个极具吸引力的治疗实体。